via www.cumc.columbia.edu
A revolutionary technique that promises to restore the sight of millions has been carried out for the first time worldwide in a British hospital.
Taking as little as 45 minutes, the procedure offers hope to those with age-related macular degeneration, the leading cause of blindness in adults globally.
It affects more than 600,000 adults in the UK, blighting the lives of a quarter of the over-60s.
In the breakthrough developed at University College London, doctors inserted a patch of stem cells into the retina of a woman who has lost her central vision.
They hope the procedure, carried out at Moorfields Eye Hospital in the capital, will restore the 60-year-old’s sight but will not know the outcome until December.
However, doctors said she suffered no complications and her eye is recovering well from the procedure.
This first operation has begun a clinical trial involving ten patients. If successful, the technique could be available on the NHS within two-and-a-half years.
The procedure, which has attracted the support of medical giant Pfizer, is carried out under local anaesthetic. It involves taking a single embryonic stem cell and growing it into a 6mm patch of 100,000 retinal pigment cells.
That patch is then rolled into a thin tube, which is injected through a tiny slit in the eye.
Once unfurled, it is placed behind the retina where scientists hope it will replace the faulty cells.
The operation is a milestone in the London Project to Cure Blindness established ten years ago with the aim of curing vision loss in patients with age-related macular degeneration.
The first step has been carried out on the wet form of the condition when a patient bleeds at the back of the eye. But scientists are confident it could also be used for the more common dry AMD, which affects 85 per cent of British sufferers.
The Latest on: Age-related macular degeneration
via Google News
The Latest on: Age-related macular degeneration
- Billy's accordion tunes among the highlights at Caithness macular group virtual ceilidhon April 17, 2021 at 1:33 am
Local accordion player Billy Mackay was among the entertainers at Caithness Macular Society Support Group's latest virtual ceilidh.
- Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene ...on April 16, 2021 at 5:07 am
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the presentation of additional clinical ...
- The global AMD and other retinal disease drugs market accounted for US$xx billion in 2020on April 15, 2021 at 9:44 am
Reportlinker.com announces the release of the report "Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market ...
- Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationon April 13, 2021 at 7:25 pm
Nonfibrillar amyloid-β oligomers (AβOs) are a major component of drusen, the sub-retinal pigmented epithelium (RPE) extracellular deposits characteristic of age-related macular degeneration (AMD), a ...
- Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)on April 13, 2021 at 5:01 am
Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today ...
- In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lineson April 13, 2021 at 4:01 am
Low energy stereotactic radiotherapy has been proposed for the treatment of neovascular age related macular degeneration. We investigated the in vitro effect of the radiotherapy on pericytes, retinal ...
- Researchers identify new potential mechanism for age-related macular degenerationon April 12, 2021 at 9:32 pm
Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular ...
- New Mechanism Identified Behind Leading Cause of Blindnesson April 12, 2021 at 12:00 pm
Findings in worms suggest structural integrity of the eye's light-sensing cells important for age-related macular degeneration Using laboratory-grown roundworms as well as human and mouse eye tissue, ...
- New mechanism identified behind blindness in older adultson April 11, 2021 at 9:00 pm
Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular ...
- LumiThera announces positive data from LIGHTSITE II clinical trial to treat age-related macular degenerationon April 10, 2021 at 1:00 am
LumiThera announces positive data from LIGHTSITE II clinical trial to treat age-related macular degeneration: Seattle Saturday, April 10, 2021, 13:30 Hrs [IST] LumiThera Inc, a me ...
via Bing News
